ArticleCureus2025
Herpes Zoster Vaccine Uptake in Saudi Arabia: Factors Influencing Adults' Willingness to Receive the Vaccine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD).Open access rheumatology : research and reviews · 2026Article
- Saudi Heart Association Position Statement on Adult Vaccinations for Patients With Cardiovascular Diseases.Journal of the Saudi Heart Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to evaluate adults' willingness to receive the herpes zoster (HZ) vaccine in Saudi Arabia and identify key factors influencing their decisions.
methodsA cross-sectional study was conducted among adults aged ≥18 years across five Saudi regions from August to September 2024. Data were collected using an Arabic electronic questionnaire covering vaccination prevalence, knowledge, willingness, barriers, and strategies to enhance HZ vaccine uptake.
resultsAmong 579 participants, only 14.3% of older adults aged 50+ years (54/377) received the vaccine, with an overall HZ vaccination rate of 10.9%. The primary motivators were healthcare provider recommendations (57.1%) and awareness of benefits (34.9%). Of non-vaccinated individuals, 51.7% expressed willingness to vaccinate if barriers were removed, while 48.3% remained unwilling. The main barrier was a lack of awareness (41.9%). Vaccination rates were significantly higher among residents of the eastern region (26.5%, p = 0.001), those aged 60+ years (25.6%, p = 0.001), and urban residents (12.6%, p = 0.004). Among the non-vaccinated, willingness to vaccinate was higher among individuals from the southern region (64.3%, p = 0.001), aged 30-49 years (53.8%, p = 0.001), urban dwellers (52.3%, p = 0.004), highly educated (56.4%, p = 0.020), recipients of other vaccines (57.7%, p = 0.001), and those with prior shingles diagnoses (57.9%, p = 0.006).
conclusionHZ vaccination remains underutilized in Saudi Arabia despite moderate awareness levels. Healthcare provider recommendations, public education, and system-level interventions are critical to improving uptake. National strategies must address disparities in access, knowledge, and provider engagement to enhance preventive healthcare outcomes for at-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.